Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage

MLA

E.L. Thomas, et al. “Safety Results of Two Phase III Trials of an Intravitreous Injection of Highly Purified Ovine Hyaluronidase (Vitrase) for the Management of Vitreous Hemorrhage.” American Journal of Ophthalmology, vol. 140, no. 4, Jan. 2005, pp. 585–97. EBSCOhost, https://doi.org/10.1016/j.ajo.2005.06.022.

APA

E.L. Thomas, L.R. Grillone, Marc D. de Smet, & Baruch D. Kuppermann. (2005). Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. American Journal of Ophthalmology, 140(4), 585–597. https://doi.org/10.1016/j.ajo.2005.06.022

Chicago

E.L. Thomas, L.R. Grillone, Marc D. de Smet, and Baruch D. Kuppermann. 2005. “Safety Results of Two Phase III Trials of an Intravitreous Injection of Highly Purified Ovine Hyaluronidase (Vitrase) for the Management of Vitreous Hemorrhage.” American Journal of Ophthalmology 140 (4): 585–97. doi:10.1016/j.ajo.2005.06.022.